Literature DB >> 14630759

Recent developments in beta lactamases and extended spectrum beta lactamases.

Joumana N Samaha-Kfoury1, George F Araj.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14630759      PMCID: PMC274061          DOI: 10.1136/bmj.327.7425.1209

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  21 in total

1.  Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test.

Authors:  M T Nüesch-Inderbinen; H Hächler; F H Kayser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

2.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

Review 3.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

4.  Effect of different beta-lactams in combination with beta-lactamase inhibitors in the presence or absence of tobramycin against some enterobacteriaceae producing extended-spectrum beta-lactamases.

Authors:  A Ferrara; C Dos Santos; M Cimbro
Journal:  Chemotherapy       Date:  1998 Sep-Oct       Impact factor: 2.544

5.  Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

Authors:  K S Thomson; C C Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

Authors:  D L Paterson; L Mulazimoglu; J M Casellas; W C Ko; H Goossens; A Von Gottberg; S Mohapatra; G M Trenholme; K P Klugman; J G McCormack; V L Yu
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

7.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Authors:  P A Bradford; C E Cherubin; V Idemyor; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.

Authors:  M G Cormican; S A Marshall; R N Jones
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV, CARB) [corrected].

Authors:  G Arlet; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1991-07-15       Impact factor: 2.742

10.  In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.

Authors:  L Martínez-Martínez; S Hernández-Allés; S Albertí; J M Tomás; V J Benedi; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

View more
  21 in total

1.  Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.

Authors:  Prathiba Kurupati; N P Ramachandran; Chit Laa Poh
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

2.  Evaluation of efficacy and tolerability of cefotaxime and sulbactam versus cefepime and tazobactam in patients of urinary tract infection-a prospective comparative study.

Authors:  Kamalpreet Kaur; Anita Gupta; Amarjeet Sharma; Geeta Walia; Bikramdeep Singh; Kiranpreet Kaur
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Antimicrobial resistance in generic Escherichia coli isolates from wild small mammals living in swine farm, residential, landfill, and natural environments in southern Ontario, Canada.

Authors:  Samantha E Allen; Patrick Boerlin; Nicol Janecko; John S Lumsden; Ian K Barker; David L Pearl; Richard J Reid-Smith; Claire Jardine
Journal:  Appl Environ Microbiol       Date:  2010-12-03       Impact factor: 4.792

4.  Antimicrobial resistance in Escherichia coli isolates from swine and wild small mammals in the proximity of swine farms and in natural environments in Ontario, Canada.

Authors:  Gosia K Kozak; Patrick Boerlin; Nicol Janecko; Richard J Reid-Smith; Claire Jardine
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

5.  First Report of OXA-4, an ESBL Isolated from Pseudomonas aeruginosa a South Indian Strain.

Authors:  S A Jemima Kingsley; Susan Verghese
Journal:  Indian J Microbiol       Date:  2012-10-31       Impact factor: 2.461

6.  Extended-spectrum β-lactamases in Gram Negative Bacteria.

Authors:  Deepti Rawat; Deepthi Nair
Journal:  J Glob Infect Dis       Date:  2010-09

7.  Characterization of Pseudomonas aeruginosa isolated from chronically infected children with cystic fibrosis in India.

Authors:  Gunjan Agarwal; Arti Kapil; Susheel Kumar Kabra; Bimal Kumar Das; Sada Nand Dwivedi
Journal:  BMC Microbiol       Date:  2005-07-21       Impact factor: 3.605

8.  A Multicenter Study of Beta-Lactamase Resistant Escherichia coli and Klebsiella pneumoniae Reveals High Level Chromosome Mediated Extended Spectrum β Lactamase Resistance in Ogun State, Nigeria.

Authors:  Folasoge A Adeyankinnu; Babatunde O Motayo; Akinniyi Akinduti; John Akinbo; Joseph I Ogiogwa; Bukola W Aboderin; R A Agunlejika
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-03-24

9.  Resistance to β-lactams in bacteria isolated from different types of Portuguese cheese.

Authors:  Paula Amador; Ruben Fernandes; Cristina Prudêncio; Luísa Brito
Journal:  Int J Mol Sci       Date:  2009-04-07       Impact factor: 6.208

10.  The Lactamase Engineering Database: a critical survey of TEM sequences in public databases.

Authors:  Quan Ke Thai; Fabian Bös; Jürgen Pleiss
Journal:  BMC Genomics       Date:  2009-08-21       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.